Quantcast
Last updated on April 18, 2014 at 11:01 EDT

Latest International Neuromodulation Society Stories

2014-03-31 08:28:22

MENLO PARK, Calif., March 31, 2014 /PRNewswire/ -- Nevro, a growth stage medical device company focused on developing innovative, evidence based solutions in the neuromodulation space, announced today the appointment of Dr. David Caraway as its Chief Medical Officer. Dr. Caraway will provide strategic direction and support the design, development, and adoption of cutting-edge therapies that aim to advance the neuromodulation field. He will also represent Nevro's mission and values in...

2014-03-20 23:22:31

Capitol Pain Institute's founder recently presented a seminar at one of the most influential fellows programs in the country. Austin, TX (PRWEB) March 20, 2014 For all medical products and services, risk management over the years has become a very important issue, and thanks to the seminar Dr. Matthew Schocket presented at the St. Jude Medical National Neuromodulation 201 Fellows Program, pain fellows now have a clear-cut strategy on reducing risk in their practices and keeping...

2013-06-13 23:16:14

Allegheny General Hospital physicians recently used deep brain stimulation (DBS) to boost the metabolism of morbidly obese patients in a pilot study. Future expanded studies will explore whether DBS could help reduce cravings and curb appetite in that patient population. Berlin (PRWEB) June 13, 2013 The first use of deep brain stimulation to the brain´s “feeding center” was associated with a weight loss trend in morbidly obese patients, according to a pilot study presented...

2013-03-25 12:27:11

DUBLIN, March 25, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/t8zp6f/neuromodulation) has announced the addition of the "Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017" report to their offering. (Logo:...

2013-02-22 23:01:23

Research and Markets announces the addition of "Neuromodulation Market — [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), & Transcranial Magnetic Stimulation (TMS)] — Forecasts to 2017" to its catalogue. (PRWEB) February 22, 2013 Neuromodulation devices have emerged as one of the fastest growing segments of the medical device market due to high demand for...

2010-09-16 09:00:00

HOUSTON, Sept. 16 /PRNewswire/ -- Ascendant Neuro is pleased to announce the addition of Kenneth Alo, M.D., an internationally recognized specialist who has joined to further the advancement of the group's minimally invasive pain treatment techniques through the innovative use of neurostimulators. Dr. Alo will serve as Director of Neuromodulation and Clinical Research. Dr. Alo graduated from Texas A&M University College of Medicine and completed his General Surgery Internship,...

2008-07-16 06:00:44

Research and Markets (http://www.researchandmarkets.com/research/83cfae/the_market_for_neu) has announced the addition of the "The Market for Neurotechnology: 2008-2012" report to their offering. This newly published market research report is the most comprehensive and up-to-date publication available covering the neurotechnology industry. The report takes an in-depth look at the technology, markets, competitors, and growth rates in four key segments of the neurotechnology industry in...